共 50 条
- [1] CONTROLLED EVALUATION OF ADRIAMYCIN (NSC-123127) IN PATIENTS WITH DISSEMINATED BREAST-CANCER CANCER CHEMOTHERAPY REPORTS PART 1, 1974, 58 (06): : 877 - 882
- [2] OVERVIEW OF STUDIES WITH ADRIAMYCIN (NSC-123127) IN UNITED-STATES CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (02): : 247 - 251
- [3] ADRIAMYCIN (NSC-123127) IN TREATMENT OF ADVANCED BREAST-CANCER - STUDIES BY SOUTHWEST-ONCOLOGY-GROUP CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (02): : 329 - 334
- [4] ADRIAMYCIN (NSC-123127) STUDIES IN ADULT PATIENTS CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (02): : 253 - 257
- [5] PHASE-II EVALUATION OF ADRIAMYCIN (NSC-123127) AS TREATMENT FOR DISSEMINATED BREAST-CANCER PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1974, 15 (MAR): : 100 - 100
- [6] EUROPEAN STUDIES WITH ADRIAMYCIN (NSC-123127) IN LUNG-CANCER CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (02): : 343 - 347
- [7] ADRIAMYCIN (NSC-123127) CARDIOMYOPATHY CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (02): : 203 - 208
- [8] CURRENT STATUS OF STUDIES WITH ADRIAMYCIN (NSC-123127) CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1973, 4 (03): : 47 - 50
- [9] ADRIAMYCIN (NSC-123127) PHARMACOLOGY CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (02): : 153 - 158
- [10] CLINICAL PHARMACOLOGY OF ADRIAMYCIN (NSC-123127) CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (02): : 183 - 185